论文部分内容阅读
目的:对莫西沙星与左氧氟沙星治疗伴有吸入因素的社区获得性肺炎患者疗效进行分析。方法:对2012年4月到2014年4月期间在我院接受治疗的80例社区获得性肺炎患者进行临床研究,随机分为对照组和研究组,对对照组使用左氧氟沙星进行治疗,对研究组使用莫西沙星进行治疗,观察比较两组患者的治疗效果。结果:研究组患者的治疗总有效率(95.0%)明显高于对照组患者(72.5%),且两组之间的差异存在统计学上的意义(P<0.05)。结论:对伴有吸入因素的社区获得性肺炎患者使用莫西沙星治疗比使用左氧氟沙星治疗的效果更佳,可在临床上进一步的推广。
OBJECTIVE: To analyze the efficacy of moxifloxacin and levofloxacin in the treatment of community-acquired pneumonia patients with inhalation factors. Methods: A total of 80 community-acquired pneumonia patients treated in our hospital from April 2012 to April 2014 were randomly divided into control group and study group, and the control group was treated with levofloxacin. The study group The use of moxifloxacin treatment, observed and compared the treatment effect of two groups of patients. Results: The total effective rate (95.0%) in the study group was significantly higher than that in the control group (72.5%), and the difference between the two groups was statistically significant (P <0.05). Conclusions: Moxifloxacin in patients with community-acquired pneumonia with inhalation factor is better than the levofloxacin treatment and can be further extended in clinic.